Ekso Bionics (NASDAQ:EKSO) Share Price Passes Below 50 Day Moving Average of $1.65

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $1.65 and traded as low as $1.40. Ekso Bionics shares last traded at $1.44, with a volume of 162,174 shares trading hands.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. StockNews.com upgraded shares of Ekso Bionics from a “sell” rating to a “hold” rating in a report on Thursday, April 4th. HC Wainwright reduced their price target on Ekso Bionics from $10.00 to $9.25 and set a “buy” rating for the company in a report on Tuesday, March 5th.

Ekso Bionics Stock Down 3.8 %

The company has a debt-to-equity ratio of 0.38, a current ratio of 2.49 and a quick ratio of 1.87. The stock has a market capitalization of $22.91 million, a price-to-earnings ratio of -1.16 and a beta of 1.61. The firm’s fifty day moving average is $1.62 and its 200-day moving average is $1.59.

Ekso Bionics (NASDAQ:EKSO) last released its earnings results on Monday, March 4th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.11). The company had revenue of $4.85 million during the quarter, compared to the consensus estimate of $4.80 million. Ekso Bionics had a negative return on equity of 90.80% and a negative net margin of 83.14%. During the same period in the previous year, the firm posted ($0.24) EPS. On average, sell-side analysts predict that Ekso Bionics Holdings, Inc. will post -0.49 earnings per share for the current year.

Institutional Investors Weigh In On Ekso Bionics

Institutional investors and hedge funds have recently made changes to their positions in the company. Dimensional Fund Advisors LP bought a new stake in Ekso Bionics in the 3rd quarter valued at about $28,000. Strategic Wealth Investment Group LLC raised its position in shares of Ekso Bionics by 25.8% during the 3rd quarter. Strategic Wealth Investment Group LLC now owns 42,665 shares of the company’s stock worth $31,000 after buying an additional 8,752 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Ekso Bionics by 153.4% in the 2nd quarter. Renaissance Technologies LLC now owns 44,606 shares of the company’s stock worth $74,000 after acquiring an additional 27,006 shares during the period. Finally, Kent Lake Capital LLC acquired a new stake in shares of Ekso Bionics in the 4th quarter worth approximately $353,000. 6.42% of the stock is owned by institutional investors and hedge funds.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.